Publications by authors named "Paula D James"

Claim this Profile
D
Diagnosis of bleeding disorder of unknown cause: how many tests are enough to diagnose BDUC?
Maria N Avgeropoulos, Paula D James

Hematology Am Soc Hematol Educ Program· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining the Impact of Combination Oral Contraceptives on Von Willebrand Factor and Factor VIII in Healthy Patients and Patients With Von Willebrand Disease: A Scoping Review and Meta-Analysis.
Eve Justason, Anna M Ishchuk, Benjamin P Ott, M E Sophie Gibson, Paula D James

Haemophilia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of age on ISTH-BAT scores and low VWF diagnosis in the Zimmerman Program.
Ferdows Atiq, Pamela A Christopherson, Dearbhla Doherty, Anne-Marije Hulshof, Sandra L Haberichter, Paula D James, James S O'Donnell

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2025 ASH ISTH NBDF WFH monitoring report on the 2021 clinical guidelines on the diagnosis and management of von Willebrand disease.
Paula D James, Veronica H Flood, Nathan T Connell

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic testing for bleeding disorders (GT4BD): protocol for a randomised controlled trial evaluating the introduction of whole genome sequencing early in the diagnostic pathway for patients with inherited bleeding disorders as compared with standard of care.
Megan Chaigneau, Mackenzie Bowman, Julie Grabell, Megan Conboy, Ana Johnson, Paula D James

BMJ Open· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Periprocedural hemostatic prophylaxis and outcomes in bleeding disorder of unknown cause.
Callie Berkowitz, Alice Ma, Vanessa Miller, Supreet Goraya, Kristi Kirkland, Paula D James

Res Pract Thromb Haemost· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The common VWF variant p.Y1584C: detailed pathogenic examination of an enigmatic sequence change.
Pamela A Christopherson, Nathalie Tijet, Sandra L Haberichter, Veronica H Flood, Justyne Ross, Paula D James

J Thromb Haemost· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What do we know about why women bleed and what do we not know?
Andra H James, Paula D James

J Thromb Haemost· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New and emerging therapies for women, girls, and people with the potential to menstruate with VWD.
Caterina Casari, Jennifer Leung, Paula D James

Blood Adv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-centered care in von Willebrand disease: are we there yet?
Grace H Tang, Jecko Thachil, Mackenzie Bowman, Carine Bekdache, Paula D James

Expert Rev Hematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Von Willebrand Disease: Gaining a global perspective.
Jamie M O'Sullivan, Ellia Tootoonchian, Baiba Ziemele, Michael Makris, Augusto B Federici, Paula D James

Haemophilia· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variability in International Society on Thrombosis and Haemostasis-Scientific and Standardization Committee endorsed Bleeding Assessment Tool (ISTH-BAT) score with normal aging in healthy females: contributory factors and clinical significance.
Dearbhla Doherty, Julie Grabell, Pamela A Christopherson, Robert R Montgomery, Barry S Coller, James S O'Donnell, Paula D James

J Thromb Haemost· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced VWF clearance in low VWF pathogenesis: limitations of the VWFpp/VWF:Ag ratio and clinical significance.
Dearbhla Doherty, Michelle Lavin, Mary Byrne, Margaret Nolan, Jamie M O'Sullivan, Paula D James, James S O'Donnell

Blood Adv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond the guidelines: how we approach challenging scenarios in the diagnosis and management of von Willebrand disease.
Mouhamed Yazan Abou-Ismail, Paula D James, Veronica H Flood, Nathan T Connell

J Thromb Haemost· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in the management of women with type 2B von Willebrand disease during pregnancy and the postpartum period: evidence from literature and data from an international registry and physicians' survey-communication from the Scientific and Standardization Committees of the International Society on Thrombosis and Haemostasis.
Predrag Miljic, Abdelrahman Noureldin, Michelle Lavin, Sajida Kazi, Analia Sanchez-Luceros, Paula D James

J Thromb Haemost· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Special considerations in GI bleeding in VWD patients.
Nicholas L J Chornenki, Edwin Ocran, Paula D James

Hematology Am Soc Hematol Educ Program· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal bleeding assessment in von Willebrand disease utilizing an interim bleeding score.
Michelle Lavin, Pamela Christopherson, Julie Grabell, Thomas Abshire, Veronica Flood, James S O'Donnell, Paula D James

J Thromb Haemost· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel cysteine substitution p.(Cys1084Tyr) causes variable expressivity of qualitative and quantitative VWF defects.
Orla Rawley, Laura L Swystun, Christine Brown, Kate Nesbitt, Margaret Rand, Paula D James

Blood Adv· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to "The 2021 von Willebrand disease guidelines: Clarity and controversy".
Paula D James, Nathan T Connell, Veronica H Flood, Reem A Mustafa

Haemophilia· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis.
Mohamad A Kalot, Nedaa Husainat, Abdallah El Alayli, Omar Abughanimeh, Osama Diab, James S O'Donnell, Paula D James

Blood Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary: surviving sexism in bleeding disorders affecting women.
Michelle Sholzberg, Paula D James

Br J Haematol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical management of patients with von Willebrand disease: summary of 2 systematic reviews of the literature.
Romina Brignardello-Petersen, Abdallah El Alayli, Nedaa Husainat, Mohamad Kalot, Shaneela Shahid, Paula D James

Blood Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gynecologic and obstetric management of women with von Willebrand disease: summary of 3 systematic reviews of the literature.
Romina Brignardello-Petersen, Abdallah El Alayli, Nedaa Husainat, Mohamad A Kalot, Shaneela Shahid, Paula D James

Blood Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trials of therapeutic heparin for COVID-19: A meta-analysis.
Michelle Sholzberg, Bruno R da Costa, Grace H Tang, Hassan Rahhal, Musaad AlHamzah, Paula D James

Res Pract Thromb Haemost· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial.
Michelle Sholzberg, Grace H Tang, Hassan Rahhal, Musaad AlHamzah, Lisa Baumann Kreuziger, Paula D James

BMJ· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis